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Abstract
Background: Within the animal kingdom, horses are among the most powerful aerobic athletic mammals. Determination of
muscle respiratory capacity and control improves our knowledge of mitochondrial physiology in horses and high aerobic
performance in general.
Methodology/Principal Findings: We applied high-resolution respirometry and multiple substrate-uncoupler-inhibitor
titration protocols to study mitochondrial physiology in small (1.0–2.5 mg) permeabilized muscle fibres sampled from
triceps brachii of healthy horses. Oxidative phosphorylation (OXPHOS) capacity (pmol O2Ns
21Nmg
21 wet weight) with
combined Complex I and II (CI+II) substrate supply (malate+glutamate+succinate) increased from 77618 in overweight
horses to 103618, 122615, and 129612 in untrained, trained and competitive horses (N=3, 8, 16, and 5, respectively).
Similar to human muscle mitochondria, equine OXPHOS capacity was limited by the phosphorylation system to 0.8560.10
(N=32) of electron transfer capacity, independent of fitness level. In 15 trained horses, OXPHOS capacity increased from
119612 to 134637 when pyruvate was included in the CI+II substrate cocktail. Relative to this maximum OXPHOS capacity,
Complex I (CI)-linked OXPHOS capacities were only 50% with glutamate+malate, 64% with pyruvate+malate, and 68% with
pyruvate+malate+glutamate, and ,78% with CII-linked succinate+rotenone. OXPHOS capacity with glutamate+malate
increased with fitness relative to CI+II-supported ETS capacity from a flux control ratio of 0.38 to 0.40, 0.41 and 0.46 in
overweight to competitive horses, whereas the CII/CI+II substrate control ratio remained constant at 0.70. Therefore, the
apparent deficit of the CI- over CII-linked pathway capacity was reduced with physical fitness.
Conclusions/Significance: The scope of mitochondrial density-dependent OXPHOS capacity and the density-independent
(qualitative) increase of CI-linked respiratory capacity with increased fitness open up new perspectives of integrative and
comparative mitochondrial respiratory physiology.
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Introduction
Muscle contraction requires ATP, and oxidative phosphoryla-
tion (OXPHOS) is the dominant pathway for providing energy
during aerobic exercise and for recovery after anaerobic exercise.
The level and contribution of OXPHOS to muscle energy supply
depends on the type, intensity and duration of exercise (for a
review, see [1]). These functional differences are well established
by comparison of aerobic versus anaerobic athletic species [2,3] or
sports athletes [4,5], and glycolytic (white) versus aerobic (red)
muscles and muscle fibres [6,7]. In contrast, limited information is
available on the functional characteristics of OXPHOS and
differences in mitochondrial respiratory control in skeletal muscle
of various species and at different levels of training [8].
Comparative physiology aims at elucidating the functional and
integrative mechanisms of complex systems such as mitochondria.
In addition, evaluation of altered mitochondrial function in health
and disease may provide the key to improve our knowledge of
pathophysiology as a basis to develop novel therapies.
Recent investigations on mitochondrial respiratory control
revealed fundamental differences of mitochondrial physiology in
skeletal muscle of humans versus rodents (reviewed by [8]). These
surprising differences of mitochondrial respiratory control have
been masked by conventional protocols of bioenergetics, using
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measurement of active and passive respiration (ADP-stimulated
and ADP-limited; States 3 and 4, respectively [9]). Under these
conditions, substrate supply to selected segments of the electron
transfer system (ETS) exerts artificial control over respiration
which prevents physiological control mechanisms from being
expressed. Maximum OXPHOS capacities are obtained in
mitochondrial preparations only on the basis of physiological
substrate combinations linked to electron transfer through CI and
CII simultaneously (CI+II), required to reconstitute tricarboxylic
acid (TCA) cycle function [8,10]. Convergent electron input
through CI+II into the Q-junction exerts an additive effect on
respiration with the consequence of a shift of metabolic control
from external substrate supply to catalytic capacities distributed
throughout the OXPHOS system [8,10–13].
Maximum OXPHOS capacity in muscle with a physiological
substrate cocktail has not yet been studied on a larger comparative
scale of different mammalian species [14]. Equine skeletal muscle
is of primary interest in comparative physiology for the following
reasons: besides the pronghorn antelope and dogs, horses are
among the most athletic species [15,16]. These active animals
consume more oxygen per unit body mass than any other
mammal. Because horses are large, the oxygen consumed in toto at
maximal exercise intensity is several-fold greater reaching more
than 100 liters per minute (for a review, see [17]). Indeed, maximal
oxygen consumption per body mass (specific VO2max) is more than
twice as high in race horses compared to elite human athletes
(.200 ml.min
21.kg
21 [18] versus 80 ml.min
21.kg
21 [19]). The up
to 50-fold increase in VO2 in rest-work transitions is achieved as a
result of remarkable cardiopulmonary adaptations: horses reach
their outstanding VO2max mainly by achieving superlative rates of
oxygen delivery [17]. This exceptional aerobic capacity of horses
has been gained over time by evolutionary selection of these
herbivores whose survival was dependent directly on speed to
escape predators and on endurance to find food and water. After
domestication, selection for high aerobic capacity has been
continued by specific breeding programs. Depending on their
breed and training, the contemporary horse may excel in different
types of disciplines requiring endurance and/or speed aptitudes.
Endurance horses may race 160 km at a mean speed of 20 km/h
and thoroughbred race horses run at high speed (,60 km/h) over
distances up to 5 km.
In horses, the major sources of energy for muscle contraction
are intramuscular glycogen and triglycerides, as well as blood-
borne glucose and fatty acids. The predominant sources of energy
and relative contribution of aerobic and anaerobic metabolism
depend on exercise type and training (for a review in horses, see
[7]).
In equestrian disciplines requiring stamina but also in
thoroughbred racing requiring speed aptitude, aerobic phosphor-
ylation contributes predominantly to ATP replenishment during
exercise. Indeed, thoroughbreds race from 1000 to 3000 m,
distances that cannot be run on the sole resort of anaerobic
pathways [20].
In horses, muscle oxidative capacity has been classically
evaluated by determining the activity of mitochondrial marker
enzymes such as succinate dehydrogenase or mitochondrial
volume density [21–24]. These histological methods do not reveal
information about integrative mitochondrial function. The first
direct measurement of respiratory capacity with a Clark oxygen
sensor was performed on mitochondria isolated from equine
muscle samples collected before and after exercise with the
percutaneous needle biopsy method [25]. This study showed that
exercise depresses transitorily muscle respiratory capacity with
NADH-linked (CI) substrates. Application of conventional mito-
chondrial respiratory protocols with substrate supply linked either
to CI or CII and restriction to States 3 and 4 have largely masked
the potential diversity of mitochondrial respiratory control
patterns in skeletal muscle of different species and at different
levels of fitness. Determination of muscle respiratory capacity with
physiological substrate cocktails is warranted to improve our
knowledge of mitochondrial physiology in horses.
Recently, a preliminary study demonstrated the feasibility to
monitor mitochondrial respiration in small samples of permeabi-
lized muscle fibres with high-resolution respirometry (HRR) in
horses [26]. Determination of OXPHOS capacity and respiratory
control patterns in horse skeletal muscle for further comparative
studies requires the development of protocols that are identical, as
far as possible, in applications to different species, but which are
also rigorously tested in and adapted to the specific constraints and
peculiarities of this large animal. The present investigation on
horse skeletal muscle has tested the methodology used to study
mitochondrial function in muscle microbiopsies by HRR [27] to
define reference protocols for horses (from sampling procedure to
data analysis). In addition, this study applied these protocols to a
large group of horses to address the following questions: (1) What is
the upper limit of tissue-OXPHOS capacity in triceps brachii muscle
of healthy horses and how does it scale with body size and
outstanding aerobic capacity of horses? (2) Is maximum OXPHOS
capacity influenced by training status and does it contribute to
performance? (3) To which extent are mitochondrial respiratory
control patterns in horse skeletal muscle comparable to skeletal
muscle mitochondria of mouse, rat and man?
Materials and Methods
Animals and muscle microbiopsy sampling procedure
All procedures of this study were approved by the Animal Ethic
Commission of the University of Liege (agreement nu07–629).
Muscle microbiopsies were obtained from 32 healthy horses
(Table 1). Horses were not owned by the University of Liege but
belonged to individual owners who gave their consent for the
horses to be biopsied. The body condition score (BCS) according
to Arnaud et al. (1997) [28] results from an evaluation of the mass
of fat deposits in five specific body locations by palpation,
complemented by visual assessment of seven anatomic sites. Each
evaluation receives a notation and the average defines the BCS
ranging from 0 (emaciated) to 5 (obese). Four fitness groups were
studied, ranging from untrained overweight, normal BCS
untrained, trained and competitive horses (Table 1).
Studies on muscle energetics in horses are primarily based upon
the use of percutaneous needle biopsies [21,29,30] which provide
50 to 150 mg of muscle wet weight (Ww) for biochemical,
histochemical, immunohistochemical, and morphological studies.
Although this quantity appears to be small compared to hundreds
of kg of muscle of horses, the technique is quite invasive and is
therefore difficult to apply as a routine procedure, especially for
sport horses. In search for a minimally-invasive procedure, we
applied the microbiopsy technique [31] to collect on average
20 mg from the triceps brachii muscle using a 14 G biopsy needle
mounted on an automatic instrument (Pro-Mag
TM Ultra Biopsy
Instrument, Angiotech, Gainesville, Fl, USA). Fibre-type distribu-
tion is not homogenous within the muscle [32,33] thus requiring
an accurate standardization of the sampling site and depth for
consistency of interpretation of results [34]. Briefly, the sampling
site was shaved (one cm
2), the skin was desensitized by
subcutaneous injection of 0.5 ml of mepivacain (scandicaine 2%,
AstraZeneca, Brussels, Belgium), and aseptically prepared. Me-
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by veterinary practitioners and it is thus readily available. Local
anaesthetics have to be injected strictly under the skin since they
may induce alteration of muscle mitochondrial energetics [35,36].
Muscle microbiopsy specimens were taken at 50 mm depth in the
long head of the triceps brachii through a skin incision made with the
tip of a scalpel blade nr 11, such that a direct effect of the
mepivacain injection on the mitochondria of the muscle biopsy
can be practically excluded. Closure of the skin incision was not
necessary, the microbiopsy procedure was completed within
15 minutes, was well tolerated by horses and sedation was not
required. Two to three muscle samples of, on average,
19.965.1 mg Ww each were obtained via the same skin opening
and transferred immediately into ice-cold relaxing solution BIOPS
[37,38] containing 10 mM CaK2-EGTA, 7.23 mM K2-EGTA,
20 mM imidazole, 20 mM taurine, 50 mM K-MES, 0.5 mM
dithiothreitol, 6.56 mM MgCl2, 5.77 mM ATP and 15 mM
phosphocreatine adjusted to pH 7.1. The fibres were kept at
4uC until further preparation.
Permeabilized muscle fibre preparation
After transferring the tissue sample into ice-cold BIOPS,
connective tissue was removed and the muscle fibres were
mechanically separated using two pairs of forceps with sharp tips.
Complete permeabilization of the plasma membrane was ensured
by gentle agitation for 30 min at 4uC in 2 ml of BIOPS solution
containing 50 mg/ml saponin. The fibre bundles were rinsed by
agitation for 10 min in ice-cold mitochondrial respiration medium
(MiR05; 0.5 mM EGTA, 3 mM MgCl2, 60 mM K-lactobionate,
20 mM taurine, 10 mM KH2PO4, 20 mM Hepes, 110 mM
sucrose and 1 g/l BSA essentially fatty acid free adjusted to
pH 7.1 [39]. The permeabilized muscle fibres (Pfi) were
immediately used for HRR.
High-resolution respirometry
One to 2.5 mg Ww (microbalance; METTLER TOLEDO,
Zaventem, Belgium) of Pfi were added to each Oxygraph-2k
chamber (OROBOROS INSTRUMENTS, Innsbruck, Austria)
containing 2 ml of MiR05 at 37.0uC maintained constant at
60.001uC by electronic Peltier regulation. Oxygen concentration,
cO2 (mM), and oxygen flux per muscle mass (pmol O2Ns
21Nmg
21
Ww) were recorded online using DatLab software (OROBOROS
INSTRUMENTS, Innsbruck, Austria).
After calibration of the oxygen sensors at air saturation, a few ml
of oxygen gas was introduced into the gas phase above the stirred
aqueous phase in the partially closed chambers to reach a
concentration of 500 mMO 2. During the complete substrate-
uncoupler-inhibitor titration (SUIT) protocols (about 1 hour), the
oxygen level in the chambers was maintained between 200 and
500 mMO 2 to avoid any oxygen limitation of respiration [27].
Whereas air-level oxygen pressure is not a limiting factor for
respirometric studies with isolated mitochondria, low oxygen levels
(,200 mMO 2) have to be avoided with Pfi because of restricted
oxygen diffusion [40]. Such oxygen dependence was also observed
in the present study with horses (data not shown) and thus, the
oxygraph chambers were reoxygenated when the O2 level in the
medium dropped towards 200 mM. Respiratory flux was corrected
on-line for instrumental background, determined at experimental
oxygen levels [41].
Three SUIT protocols were applied to obtain extended
information on coupling and substrate control parameters [27].
From the 32 horses included in the study, 15 were used for
simultaneous application of all three SUIT protocols.
In SUIT1 (Figure 1A), electron flow through CI was supported
by the NADH-linked substrates glutamate+malate (GM; 10 and
2 mM) with subsequent addition of ADP (2.5 mM). ADP-
stimulated respiration with various substrate combinations (State
3 [9]) represents OXPHOS capacity (State P), if limitation by ADP
or oxygen is strictly avoided [8]. High ADP concentrations are
required to overcome the low affinity for ADP in Pfi as compared
to isolated mitochondria [42]. In SUIT2, the initial substrates were
pyruvate+malate (PM; 5 and 2 mM) with subsequent stimulation
of OXPHOS by glutamate (10 mM; G; Figure 1B). Under aerobic
conditions, pyruvate is converted to acetyl-CoA by the pyruvate
dehydrogenase (PDH) complex with concurrent reduction of
NAD
+ [43]. The PDH complex of eukaryotic cells is located in the
mitochondrial matrix and thus, is not lost during permeabilization.
Surprisingly, addition of 5 mM pyruvate to glutamate+malate
exerted a significant inhibition of OXPHOS capacity, but this
effect was not seen upon stepwise titration of pyruvate (data not
shown), indicating the importance of optimizing tissue-specific
details of SUIT protocols before initiating an experimental series.
The next steps were identical in both protocols, adding
succinate (S; 10 mM) for convergent electron flow through CI+II
into the Q-junction (supported by GMS or PMGS in SUIT1 or 2,
respectively). The capacity of the phosphorylation system (adenine
nucleotide translocase, inorganic phosphate transporter, and ATP
synthase) may limit OXPHOS capacity with an apparent excess
capacity of the ETS over the phosphorylation system [8,10–12].
This was tested by stepwise addition of the uncoupler FCCP
(0.05 mM, followed by 0.025 mM steps until maximal oxygen flux
was reached), obtaining ETS capacity, E, with convergent electron
flow through CI+II. Higher concentrations of FCCP were
Table 1. Characteristics of horses used in the study.
Subgroup N BCS Age (years) Sex Breed Equestrian discipline
Overweight 3 4.760.3 10.364.6 F (3) Arabian (1), Half-blood (1), Standardbreds (1) Endurance (1), Leisure (2)
Untrained 8 3.160.7 6.663.3 F (5), G (3) Arabian (3), Crossbred Arabian (1),
Half-blood (4)
Dressage (1), Endurance (4),
Eventing (1), Jumping (2)
Trained 16 3.060.3 8.263.3 F (3), G (12), E (1) Arabian (7), Crossbred Arabian (3),
Half-blood (1), Standardbreds (5)
Endurance (11), Racing (5)
Competitive 5 3.060.6 8.661.7 F (2), G (3) Arabian (3), Standardbreds (2) Endurance (3), Racing (2)
Trained matched
SUIT 2&3
15 3.060.4 7.362.9 F (4), G (10), E (1) Arabian (6), Crossbred Arabian (1),
Half-blood (1), Standardbreds (7)
Endurance (8), Racing (7)
Values are means6SD; BCS: body condition score; F: female; G: gelding; E: entire; N is the number of horses investigated and the number in parentheses is the number
of horses with the mentioned characteristic.
doi:10.1371/journal.pone.0034890.t001
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PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e34890Figure 1. Respirometric protocols with permeabilized fibres from horse skeletal muscle (triceps brachii). A: SUIT1 protocol with electron
flow through CI supported by glutamate+malate. B: SUIT2 protocol with electron flow through CI supported by pyruvate+malate. C: SUIT3 protocol
with electron flow through CII. Left panels: Oxygen concentration (mM; blue lines) and muscle mass-specific oxygen flux (pmol O2?s
21?mg
21 wet
weight; red lines). Marked sections correspond to steady-state fluxes at different coupling states (L, P and E) and substrate states. Numbers on top of
traces are ROX-corrected tissue mass-specific fluxes at various metabolic states, and ROX (pmol O2?s
21?mg
21). Right panels: Coupling/substrate
control diagrams with flux control ratios (FCR) normalized relative to ETS capacity with convergent CI+II electron input (values framed). Values linked
to vertical and horizontal arrows are coupling control ratios (L/P and P/E ratio), and substrate control ratios (CI/CI+II in the OXPHOS state). FCR linked
by arrows directly to the reference state are also coupling control ratios (P/E) or substrate control ratios (CII/CI+II). Whereas internal FCR are obtained
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ETS capacity is distinguished from generally uncoupled respira-
tory states with various degrees of activation or inhibition [27].
Electron input into the Q-junction through CII alone was
subsequently induced by inhibition of CI by rotenone (Rot;
0.5 mM). Finally, residual oxygen consumption (ROX) was
obtained by addition of antimycin A (2.5 mM) to block electron
transfer through Complex III (CIII). Inhibition requires a long
time to be reached with the sole addition of this inhibitor in
human [12] and horse fibres (this is tissue- and species specific). In
our study, we provided the necessary time to obtain steady-state
ROX. Oxygen fluxes were corrected by subtracting ROX from
each measured mitochondrial steady-state. Antimycin A is not the
only choice to obtain ROX after inhibition of the ETS at the level
of CIII. Myxothiazol (0.5 mM; not used in the present study)
provides an alternative [27]. Inhibition of Complex IV (CIV) by
cyanide or azide cannot be used in our protocols because cyanide
inhibition is reversed by keto acids pyruvate and a-ketoglutarate,
added in our experiments and produced in the TCA cycle,
respectively. In addition, the reversibility of this inhibition is
particularly effective at the high oxygen levels required in
experiments with permeabilized fibres [27,44].
Integrity of the outer mitochondrial membrane was tested by
adding 10 mM cytochrome c [45] after ADP in the presence of
substrates feeding electrons into CI. The cytochrome c test was
applied on all samples in SUIT1 and 2. Injury of the outer
mitochondrial membrane leads to loss of cytochrome c from the
mitochondria, and to significant stimulation of respiration
following addition of exogenous cytochrome c to the respiration
medium.
An additional protocol (SUIT3; Figure 1C) was applied with the
single substrate succinate (10 mM) in the presence of rotenone
(0.5 mM), obtaining a sequence of coupling states for CII-
respiration in the absence of adenylates (LEAK), stimulated by
2.5 mM ADP (OXPHOS), and uncoupled by 0.05 mM FCCP
(ETS; additional FCCP titrations did not increase flux). Finally,
ROX was obtained with 2.5 mM antimycin A.
The average 20 mg Ww of muscle tissue collected per
microbiopsy was sufficient to perform three SUIT protocols using
1.0 to 2.5 mg of Pfi per chamber. This amount was small
compared to the (at least) 100 mg of muscle needed to isolate
mitochondria for functional studies [46]. About 1.5 mg of Pfi were
found to be the ideal amount of muscle tissue to be used for
respirometric studies with healthy horses, to obtain a good
resolution of flux and yet avoiding a too rapid decline of oxygen
concentration which would require frequent reoxygenations.
Oxygen flux was expressed as tissue mass-specific respiration
(per mg Ww), or as flux control ratios, FCR, with internal
normalization for maximum ETS capacity in each experimental
run. Depending on the protocol, the FCR (ranging from 0 to 1) are
a function of coupling control only (SUIT3), or are a complex
function of coupling and substrate control. Coupling control ratios,
CCR, such as the LEAK control ratio, L/E, and phosphorylation
system control ratio, P/E, are obtained at constant substrate
supply, whereas substrate control ratios, SCR, are flux ratios at
constant coupling state [8].
In a preliminary experiment, three untrained horses were
sampled to test the preservation of muscle samples over time
(SUIT1 and 2). Five microbiopsy specimens of muscle per horse
were taken at 50 mm depth via the same skin opening. Each
specimen was transferred immediately into 10 ml BIOPS solution
and kept at 4uC until preparation for respirometry measurements
that were performed from day 1 (as soon as possible after
sampling) to day 5 in a random order. Respirometry measure-
ments of each specimen were performed in duplicate for each
protocol.
Statistical analyses
All results are presented as mean6SD. The Wilcoxon signed-
rank and Mann-Whitney-Wilcoxon tests were used to compare
paired data (i.e. respirometric parameters among the same horses:
OXPHOS and ETS capacities obtained with CI+II substrate
combinations in SUIT1 and 2 and S(Rot) in coupled and/or
noncoupled states in SUIT1, 2 and 3) and unpaired data (i.e.
horses with different fitness level: optimal BCS and untrained versus
optimal BCS and trained versus competitive horses with optimal
BCS in SUIT1: OXPHOS and ETS capacities, FCR and SCR),
respectively. A value of P,0.05 was considered as level of
significance. Statistical analyses to test preservation of muscle
tissue over time were performed using SAS (SAS 9.1, procedure
GLM). After checking for normality, a linear model with the fixed
effects of day was used for each respirometric parameter, SCR and
FCR.
Results
Effects of training and body condition score on
mitochondrial respiratory capacity and control
Maximum tissue mass-specific OXPHOS and ETS capacities
with physiological CI+II substrate combinations increased 1.7-fold
as a function of BCS and training level (Figure 2). The overweight,
untrained and trained groups reached 0.60, 0.80, and 0.94 of the
OXPHOS or ETS capacity of the competitive horses.
CI-linked respiratory capacity increased over-proportionally as
a function of physical fitness level, thus indicating a qualitative
change of respiratory capacity in addition to the density-
dependent effect on OXPHOS and ETS capacity (Figures 3A
and B; Table 2). The specific training effect on mitochondrial
quality becomes particularly apparent when considering only
horses with normal BCS, by excluding the overweight-untrained
group: the slopes between CI-linked OXPHOS capacity and
either CI+II- or CII-linked respiratory capacities are then
apparently linear and non-proportional (significant negative
intercept; stippled lines in Figures 3A and B), demonstrating that
CI-linked OXPHOS capacity declines more steeply in untrained
versus trained horses than CII-respiration. The CIP/CI+IIP
substrate control ratio was significantly higher in competitive
horses than in the other groups (Table 3). In contrast, CII-linked
ETS capacity increased linearly and proportionally with CI+II-
linked ETS capacity as a function of physical fitness, indicating a
conserved functional response to changes in BCS and training
(Figure 3C). Similarly, the CI+II-linked OXPHOS capacity
increased proportionally with CI+II-linked ETS capacity as a
function of fitness, such that the P/E ratio remained invariable at
0.85 (N=32), indicating a constant limitation of OXPHOS by the
phosphorylation system independent of BCS and fitness level
(Figure 3D). CI+II-linked and CII-linked respiratory capacities,
therefore, qualify as functional markers of mitochondrial density,
whereas CI-linked OXPHOS capacity highlights specifically the
fact that qualitative changes are superimposed on a shift in
in SUIT 1 and 2 (A and B), the FCR for SUIT3 (C) are calculated for the externally determined reference state (Ref in C averaged from SUIT1 and 2
protocols).
doi:10.1371/journal.pone.0034890.g001
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PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e34890Figure 2. OXPHOS and ETS capacity (pmol?s
21?mg
21 wet weight) with CI-, CI+II- and CII-substrate supply as a function of physical
fitness level (SUIT1 protocol). From light gray to dark gray: overweight-untrained (N=3)R untrained with optimal body condition score (BCS;
N=8)R trained with optimal BCS (N=16) R competitive with optimal BCS (N=5); N: number of horses.
doi:10.1371/journal.pone.0034890.g002
Figure 3. Substrate and coupling control of tissue mass-specific mitochondrial respiratory capacity (pmol?s
21?mg
21 wet weight) in
skeletal equine muscle at different levels of fitness. A: Substrate control of CI- versus CI+II-linked OXPHOS capacity; CI: glutamate+malate
(GM); CI+II: glutamate+malate+succinate (GMS). B: Substrate control of CI- versus CII-linked respiratory capacity; CII: succinate+rotenone, S(Rot).
Dashed lines: linear trend for normal BCS horses, extrapolated to zero; CI-linked capacity increases overproportionally with fitness level. C: Substrate
control of CII- versus CI+II-linked ETS capacity (GMS) increasing in constant proportion with fitness level. D: Coupling control of OXPHOS versus ETS
capacity with CI+II-linked electron input (GMS). The slopes (full lines, forced through zero) provide an estimate of the CII/CI+II substrate control ratio
(C) and P/E coupling control ratio (D). All axes are scaled at 110% of the maximum value (average of competitive horses). Open squares: overweight-
untrained; closed circles, triangles and diamonds: normal BCS – untrained, trained and competitive, respectively.
doi:10.1371/journal.pone.0034890.g003
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capacity but also mitochondrial quality was modified in as a
function of physical fitness, as revealed by the substrate control
ratios.
Additive effect of multiple CI-linked substrates and
evaluation of SUIT protocols
Addition of 5 mM pyruvate to glutamate+malate resulted in a
transient inhibition of OXPHOS, whereas stepwise addition of
pyruvate to the final 5 mM concentration was without inhibitory
effect (data not shown). These observations prompted us to apply a
second protocol (SUIT2) in a matched group of trained horses,
starting with pyruvate+malate (Figure 1B). The OXPHOS
capacity with pyruvate+malate was 1.4-fold higher compared to
glutamate+malate. Addition of glutamate exerted a further 1.08-
fold stimulatory substrate control effect, which was not masked in
the presence of succinate, since OXPHOS capacity was 1.13-fold
higher with PMGS compared to GMS. The conventional
glutamate+malate and pyruvate+malate substrate combinations,
therefore, yield only 0.46 (N=32; data not reported in the table) and
0.64 (Tables 4 and 5; trained matched SUIT1 and 2; N=15) of
physiological OXPHOS capacity with the PMGS substrate
cocktail.
Tables 6 and 7 report OXPHOS and ETS capacities and
coupling control based on CII-substrate only (SUIT3 protocol)
and matched with SUIT1 and 2 protocols. The CII-linked ETS
capacity was identical in all three protocols (9869, 96626, and
97621 pmol O2?s
21?mg
21 Ww in SUIT1, 2 and 3, respectively)
with intra-individual variability due to tissue heterogeneity [47].
Coupling control and limitation of OXPHOS capacity by
the phosphorylation system
Coupling control was independent of fitness, with a mean
respiratory control ratio (RCR=P/L with glutamate+malate) of
13.568.3, and a FCR for GML/GMSE of 0.0460.03 (N=32). The
RCR for glutamate+malate and pyruvate+malate were similar (i.e.
15.6 and 12.7 in trained matched SUIT1 and 2, respectively;
N=15). In contrast, the RCR for succinate+rotenone was only
3.35, which is surprisingly low considering theoretical P:O ratios
[48] and the higher capacity of CII- compared to CI-linked
respiration.
OXPHOS and ETS capacity (CI+II) increased linearly and
proportionally with fitness (Figure 3D). The corresponding
phosphorylation system control ratios, P/E, were 0.8460.08 in
SUIT1 and 0.7160.09 in SUIT2 for trained horses (paired data;
N=15). With succinate+rotenone, the P/E ratio was 0.9760.05
(Table 7), demonstrating that uncoupling does not significantly
stimulate CII-linked OXPHOS capacity.
Preservation of permeabilized muscle fibres
OXPHOS and ETS capacities with CI2, CII2, and CI+II-
linked substrates did not significantly change for 5 days of cold
storage of tissue samples nor was there any significant change in
FCR and SCR (Figure 4). Integrity of the outer mitochondrial
Table 2. Respiratory parameters from substrate-uncoupler-inhibitor titration protocol 1 (SUIT1) applied on equine permeabilized
fibres of triceps brachii: OXPHOS and ETS capacities according to fitness level (N=32).
Subgroup OXPHOS capacity (pmol O2.s
21.mg
21) ETS capacity (pmol O2.s
21.mg
21)
CI: GMP CI+II: GMSP CI+II: GMSE CII: S(Rot)E
Overweight 35607 7 618 93617 64611
Untrained 49
a613 103
a618 121
a613 87
a613
Trained 59
a611 122
b615 143
b616 98
b69
Competitive 71
b610 129
b612 153
b619 106
b67
Trained matched SUIT 2&3 59±12 119±12 142*±18 98±9
Comments: between subgroups, respiratory parameters with different letter in superscripts are significantly different (P,0.05). No statistical analysis was performed for
the overweight group (N=3). Within SUIT1, OXPHOS and ETS capacities with CI+II substrate combinations were significantly different with P,0.001 (*). Values are
means6SD. For abbreviations, see text.
doi:10.1371/journal.pone.0034890.t002
Table 3. Respiratory parameters from substrate-uncoupler-inhibitor titration protocol 1 (SUIT1) applied on equine permeabilized
fibres of triceps brachii: flux control ratio (FCR, with normalization for CI+IIE) and substrate control ratio (SCR, assuming CIIE=CIIP);
(N=32).
Subgroup FCR SCR
CIL/CI+IIE CIP/CI+IIE CI+IIP/CI+IIE (P/E)C I I E/CI+IIE CIP/CI+IIP CIIE/CI+IIP CIP/CIIE
Overweight 0.0560.01 0.3860.08 0.8560.24 0.7060.12 0.4660.11 0.8460.11 0.5560.09
Untrained 0.04
a60.04 0.40
a,b60.07 0.85
a60.10 0.72
a60.09 0.48
a60.09 0.85
a60.10 0.58
a60.17
Trained 0.05
a60.03 0.41
b60.05 0.86
a60.07 0.69
a60.07 0.48
a60.06 0.81
a60.06 0.60
a60.09
Competitive 0.04
a60.00 0.46
a60.03 0.84
a60.09 0.69
a60.05 0.56
b60.08 0.83
a60.04 0.67
a60.07
Trained matched SUIT 2&3 0.04±0.03 0.41±0.05 0.84±0.08 0.70±0.08 0.50±0.08 0.83±0.05 0.60±0.09
Comments: between subgroups, respiratory parameters with different letter in superscripts are significantly different (P,0.05). No statistical analysis was performed for
the overweight group (N=3). Values are means6SD. For abbreviations, see text.
doi:10.1371/journal.pone.0034890.t003
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in BIOPS at 4uC for up to 5 days, as indicated by the cytochrome c
test where stimulation of respiration (#15%) was not significantly
increased. From the 60 runs performed in the preservation
experiment, nine had to be rejected due to significant cytochrome
c stimulated respiration (2 at days 1 and 2; 1 at day 3; 1 at day 4;
and 3 at day 5). Other signs of mitochondrial alterations observed
at day 5 (although without cytochrome c effect) were generally
reduced respiration except at the level of S(Rot)E. Low rates of
respiration were observed for some samples weighing ,1m gWw.
Only measurements showing none of the above-mentioned signs
of mitochondrial alteration were considered in the final analysis.
Discussion
Methodological issues
This study applied to horses the methodology used to investigate
mitochondrial function in muscle microbiopsy by HRR [27]. Two
reference protocols (SUIT1 and 2) were established for horse
skeletal muscle. The evaluation and extension of standardized
methods is a prerequisite for gaining a new perspective on
integrative and comparative mitochondrial physiology.
Reference muscle. The triceps brachii muscle was selected
because of its propulsive and postural role. In horses, the triceps
brachii is the most important extensor of the elbow and a part of the
postural apparatus used to keep the elbow fixed. These roles
determine a mixed composition of type I (slow-twitch) and type II
(fast-twitch) fibres [32], comparable to human vastus lateralis
[49,50]. Importantly, the triceps brachii is safer to access for the
investigator than the propulsive muscles of the hindlimb. In
addition, the hindlimb muscles include a greater proportion (up to
90% in thoroughbred horses) of type II fibres [32], thus rendering
them less useful for screening the mitochondrial function.
Stability of muscle sample. The equine muscle samples can
be stored at 4uC in BIOPS for at least 4 days with good
preservation of mitochondrial respiratory function. This storage
time is much longer than for human skeletal muscle that can be
conserved for only approximately 24 hours [51] or human cardiac
muscle with cold storage times limited to 9–12 hours [52]. The
stability over several days provides the possibility for transport of
muscle samples (under controlled temperature) before analysis of
mitochondrial respiration by HRR. Our study involved healthy
horses and preservation of mitochondrial function in diseased
horses might differ. In case, we recommend to analyze
mitochondrial respiration as soon as possible following sampling.
Specific experimental conditions and mitochondrial
pathways. Respirometric experiments were performed at
physiological temperature (37uC), with high ADP concentration,
no substrate limitation and with a strict control of the level of
oxygen in the oxygraph chambers.
In SUIT1 and 2, the maximum oxygen fluxes obtained after
addition of optimal uncoupler concentration indicated that the
phosphorylation system exerts control over coupled respiration.
On the other hand, the phosphorylation system did not limit CII-
respiration since addition of FCCP did not significantly stimulate
S(Rot)P. Therefore, S(Rot)P may be estimated from S(Rot)E
obtained in SUIT1 and 2.
The low P/E ratio in SUIT2 and SUIT1 with CI+II electron
supply, and the absence of an uncoupling effect in SUIT3 (P/E
close to 1) are explained by the low ADP:O ratio with CII as
compared to CI electron input, and by upstream limitation of flux
when succinate is the sole substrate. The capacity of the
phosphorylation system becomes saturated and thus limiting when
oxygen flux is higher and more ADP is phosphorylated per oxygen
consumed with combined CI+II electron input, involving proton
translocation at CI, CIII and CIV. At lower oxygen flux with
succinate only, and lower ADP:O with coupling restricted to CIII
and CIV, the capacity of the phosphorylation system is sufficiently
high to match the ETS capacity, with the consequence of an
increase of P/E to 1. Similarly, the higher ETS capacity with
pyruvate+malate+glutamate+succinate versus glutamate+malate+
succinate explains the lower P/E ratio with PMGS versus GMS.
SUIT1 and 2 protocols differ by the addition of pyruvate, the
product of glycolysis thus studying mitochondrial respiration with
Table 4. Respiratory parameters from substrate-uncoupler-inhibitor titration protocol 2 (SUIT2) applied on equine permeabilized
fibres of triceps brachii: OXPHOS and ETS capacities in trained horses (N=15; trained horses matched with SUIT1 and SUIT3
protocols).
OXPHOS capacity (pmol O2.s
21.mg
21) ETS capacity (pmol O2.s
21.mg
21)
CI: PMP CI: PMGP CI+II: PMGSP CI+II: PMGSE CII: S(Rot)E
83±23 90±25 134±37 187*{±39 96±26
Comments: within SUIT2, OXPHOS and ETS capacities with CI+II substrate combinations are significantly different with P,0.001 (*). Between SUIT1 and 2, ETS capacity
with CI+II substrate combinations is significantly different with P,0.01 ({). Values are means6SD. For abbreviations, see text.
doi:10.1371/journal.pone.0034890.t004
Table 5. Respiratory parameters from substrate-uncoupler-inhibitor titration protocol 2 (SUIT2) applied on equine permeabilized
fibres of triceps brachii: flux control ratio (FCR, with normalization for CI+IIE) and substrate control ratio (SCR, assuming CIIE=CIIP);
(N=15; trained horses matched with SUIT1 and SUIT3 protocols).
FCR SCR
CI:PML/CI+IIE CI:PMP/CI+IIE CI:PMGP/CI+IIE
CI+IIP/CI+IIE
(P/E)C I I E/CI+IIE CI:PMP/CI+IIP CI:PMGP/CI+IIP CIIE/CI+IIP CI:PMP/CIIE CI:PMGP/CIIE
0.04±0.01 0.45±0.06 0.48±0.06 0.71±0.09 0.52±0.08 0.64±0.07 0.68±0.06 0.73±0.09 0.87±0.16 0.94±0.13
Values are means6SD. For abbreviations, see text.
doi:10.1371/journal.pone.0034890.t005
Mitochondrial Respiratory Capacity in Horse
PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e34890(SUIT 2) or without (SUIT 1) assessment of aerobic glycolysis
through the activity of the PDH complex.
The minimally invasive character of the sampling technique, the
feasibility of the microbiopsy under field conditions, and the long
preservation of muscle samples open new perspectives for equine
sports medicine, such as the study of the effect of racing by
sampling horses before and after a race [26]. The protocols
described in this study are proposed as reference guidelines for
studies of mitochondrial respiratory control in the equine field,
providing the basis for extending investigations to include fatty
acid and a-glycerolphosphate oxidation.
Integrative and comparative physiology
What is the upper limit of tissue-OXPHOS capacity in triceps brachii
muscle of healthy horses and how does it scale with body size and outstanding
aerobic capacity of horses?
Maximal OXPHOS capacity has been rarely measured in
trained horses [26]. We found that OXPHOS capacity with CI+II
ranged from 60 to 150 pmol O2?s
21?mg
21 Ww,( i.e. from 80 to
201 ml O2?min
21?kg
21 Ww) increasing with fitness level from
overweight to competitive horses. This is comparable to the range
of OXPHOS capacity of human vastus lateralis increasing from 60
to 180 pmol O2?s
21?mg
21 Ww as a function of sedentary-
overweight to athletic life styles [8].
With isolated mitochondria and NADH-linked substrates only
(including pyruvate), maximal respiratory capacity is equivalent to
115 pmol O2?s
21?mg
21 Ww (155 ml O2?min
21?kg
21;3 7 uC) of
tissue [25] in accordance with our results on trained horses
(Table 2). The highest OXPHOS capacity was obtained in
competitive horses (presumably with high VO2max) with a
calculated mitochondrial oxygen consumption of 4.2 ml
O2.min
21.ml
21 mitochondria (assuming a mean mitochondrial
volume density based on Kayar et al. [23] of 75.10
26 ml.mg
21).
These values are in the range of 3–5 ml O2.min
21.ml
21
mitochondria obtained from morphometric data correlated to
VO2max in various mammals [53].
Assuming that 100% of the ergometric VO2max is consumed by
skeletal muscle mitochondria in quadrupedal mammals, Kayar
and collaborators [23] calculated a mitochondrial oxygen
consumption of 4.5 ml O2.min
21.ml
21 mitochondria in three
horses at VO2max of 60.8 l O2.min
21. By plotting VO2max against
total muscle mitochondria in several athletic and sedentary species,
a mean mitochondrial oxygen consumption of 4.960.4 ml
O2.min
21.ml
21 mitochondria is found [3,54]. Therefore, despite
the large difference in VO2max between athletic versus non-athletic
mammals, mitochondrial oxygen consumption appears to be fixed
among species including horses [23,54].
Our results suggest that higher oxidative capacity in trained
versus competitive horses is not only obtained by biogenesis of more
mitochondria of the same kind. In addition, fine-tuning of
mitochondrial quality was observed. CI-linked respiratory capacity
was increased in competitive horses to a larger extent than CII-
linked respiration, and CI/CI+II but not CII/CI+II substrate
control ratios were significantly increased (Tables 2 and 3).
Therefore, the additive effect of simultaneous electron flow
through CI and CII was not constant. This result extends our
observations obtained in a previous study showing an over-
proportional increase (+67%; significant with P,0.05) of CI-linked
respiratory capacity in untrained horses following 10 weeks of
endurance training versus CII-linked respiration (+24% ; non
significant) [26]. Taken together, training in horses stimulates
mitochondrial biogenesis resulting in increased mitochondrial
densities [55–57] within and across species, in the transition from
an inactive to physically active life style or evolutionary trait [58].
But contrary to an exclusively quantitative effect on mitochondrial
density [58], training exerts an additional influence on mitochon-
drial quality, as shown by the over-proportional increase in CI-
linked respiratory capacity with physical fitness level.
Studies on gene expression in equine skeletal muscle following
exercise and training have highlighted the roles of genes
responsible for OXPHOS, glucose metabolism and fatty acid
utilization [59–61], but experimental analyses related to the
organization of the ETS in equine mitochondria are still lacking.
Hypothetically, OXPHOS capacity might be enhanced by
biogenesis and/or a differential regulation of CI versus CII since
there are evidences that Complexes I and III in mammals
associate as supercomplexes that behave like a single unit
enhancing electron flow by direct channeling of ubiquinone (for
a review, see [62]). Supercomplex organization might also play a
role in limiting ROS formation in the trained horse. Also, the
possible role of mitochondrial dynamics on energy production
starts to be evoked [63] and may contribute to explain our
observation.
Is maximum OXPHOS capacity influenced by training
status and does it contribute to performance? His-
tochemical and immunohistochemical assays demonstrate that
training improves oxidative capacity in horse muscles [64–66].
Results of HRR reflected the fitness level of horses: the lowest
OXPHOS capacities were observed in overweight and untrained
horses, whereas competitive horses had the highest respirometric
parameters.
The VO2max is considered as the gold standard for prediction of
athletic ability [67], but performance of horses is also correlated
with specific muscle characteristics [68–70]. The highest fluxes
found in competitive horses suggest a possible link between
respirometric parameters and athletic abilities of horses [26]. A
greater extraction of oxygen within the working muscle reduces
Table 6. Respiratory parameters from substrate-uncoupler-
inhibitor titration protocol 3 (SUIT3) applied on equine
permeabilized fibres of triceps brachii: OXPHOS and ETS
capacities in trained horses (N=15; trained horses matched
with SUIT1 and SUIT2 protocols).
OXPHOS capacity (pmol
O2.s
21.mg
21)
ETS capacity
(pmol O2.s
21.mg
21)
CII: S(Rot)P CII: S(Rot)E
95±21 97±21
Values are means6SD. For abbreviations, see text.
doi:10.1371/journal.pone.0034890.t006
Table 7. Respiratory parameters from substrate-uncoupler-
inhibitor titration protocol 3 (SUIT3) applied on equine
permeabilized fibres of triceps brachii: coupling control ratio
(CCR); (N=15; trained horses matched with SUIT1 and SUIT2
protocols).
CCR
L/E P/E
0.32±0.09 0.97±0.05
Values are means6SD. For abbreviations, see text.
doi:10.1371/journal.pone.0034890.t007
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higher rates of aerobic ATP resynthesis during an effort are
decisive to delay fatigue and to ensure performance. Further
studies are required to evaluate HRR for performance prediction
in specific equestrian disciplines.
To which extend are mitochondrial respiratory control
patterns in horse skeletal muscle comparable to skeletal
muscle mitochondria of mouse, rat and man?. Respiratory
capacities obtained with glutamate+malate, pyruvate+malate or
pyruvate+malate+glutamate yielded only 5068%, 6467% and
6866% of the flux obtained with further addition of succinate
(N=15, trained horses). The additive effect of convergent electron
flow through CI+II in equine mitochondria is comparable to
skeletal muscle mitochondria of mouse, rat and man, confirming
that measurement of the upper limit of tissue-OXPHOS capacity
requires reconstitution of the TCA cycle with electron transfer
through CI and CII simultaneously [8,10–12].
The FCR in SUIT1 and 2 indicated that the phosphorylation
system exerts control over coupled respiration. This is similar in
human and rat skeletal muscle [10,11,71–73], but different in
mouse skeletal muscle (P/E=1) [13]. In human subjects, a 10-
weeks program of endurance and strength training induced an
increase of the P/E ratio from 0.85 to 0.96 [12]. By comparison,
equine OXPHOS capacity was limited by the phosphorylation
system to 0.8560.10 (i.e. SUIT1) of ETS capacity, but was
independent of fitness level in the present and previous studies
[26]. There was a wide range of P/E ratios from 0.69 to 0.96
among individuals independent of training status. The magnitude
of this apparent excess ETS over OXPHOS capacity might be an
important parameter to determine possible capacity for athletic
improvement: are trained horses with a P/E close to 1 at their
maximal capacity of functional adaptation to training? This
important question for trainers deserves an answer by conducting
additional studies in competitive horses.
Comparative mitochondrial physiology reveals similarities and
differences between human and horse skeletal muscle, based on
results of this study (and unpublished complementary data; Votion
and collaborators) for horses and humans [12]. In both species,
CII-linked ETS capacity is an invariant proportion of ETS
capacity with convergent CI+II electron input, and the corre-
sponding CII/CI+II substrate control ratio does not change with
training. Tissue mass-specific CI+II ETS capacity, therefore, is a
functional marker of mitochondrial density, which increases with
physical fitness in both species. It is well established that
mitochondrial biogenesis is stimulated by training [55–57].
However, the study from Pesta and collaborators [12] showed
that mitochondrial tissue density is not the sole determinant of
increased oxidative capacity per muscle mass. CIP/CIIE was low
in inactive horses (,0.60) and increased in competitive horses
(0.67), where it was still low compared to humans (.0.80). This
suggests that there is an apparent excess capacity of CII- over CI-
linked respiration in horses, which declined with physical fitness.
During a training season of endurance horses, OXPHOS capacity
supported by NADH-liked substrates was significantly increased
after 10 weeks of endurance training whereas the increase of
OXPHOS capacity at the level of CII was less, reaching
significance only after an additional period of 10 weeks of training
[26]. In human muscle, with a higher CI/CII ratio, CII-linked
Figure 4. Preservation of respiratory capacities and flux control ratios during extended cold storage of equine skeletal muscle.
OXPHOS and ETS capacity (pmol?s
21?mg
21 wet weight) with CI+II electron input, and corresponding flux control ratios, with protocol SUIT1 (A and
B) and SUIT2 (C and D). Non-significant changes over a period of 5 days. Each symbol is the mean value 6SD (n=2) for the N=3 horses sampled. All
flux control ratios were normalized for CI+IIE.
doi:10.1371/journal.pone.0034890.g004
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change is already present after 10 weeks of training [12].
In conclusion, horses present adaptations at the level of their
muscle mitochondrial function which preclude transposition of
results from human studies (e.g. training strategies to improve
skeletal muscle OXPHOS capacity and aerobic power).
Perspectives
Results of this study emphasize the potential limiting role of
mitochondria in muscle energetics. A prominent characteristic of
human patients with OXPHOS disorders is a greatly reduced
VO2max with concomitant deficit in peripheral oxygen extraction
[74]. Application of HRR in horses suffering from exercise
intolerance provides a powerful diagnostic tool for functional
evaluation of mitochondrial disorders.
Recently, gene expression analysis in muscle biopsies of French
draft horses suffering from a glycogenosis described as polysac-
charide storage myopathy revealed down-regulation of several
mitochondrial and nuclear genes involved in OXPHOS [75].
Altered OXPHOS might also play a central role in the
pathogenesis of atypical myopathy [76–78], a highly fatal
environmental condition that affects grazing horses [79]. Our
fundamental understanding of the pathophysiology of inherited
and acquired equine myopathies will be improved by detailed
diagnosis of mitochondrial function, as shown by the direct link
between mitochondrial function and physical fitness, including
obesity in untrained horses. Ultimately, advances in understanding
the role of mitochondrial respiratory capacity in equine fitness and
myopathies will extend the conceptual basis required to interpret
the diversity of mitochondrial function in other species, including
mouse and man.
Conclusions
This paper proposes a reference method for screening
mitochondrial respiratory function in horses. The small amount
of muscle obtained by the minimally invasive microbiopsy
technique is sufficient for testing the mitochondrial function in
Pfi with multiple SUIT protocols using HRR. Standardized
methods are described to collect, store and prepare the muscle
sample, to measure the mitochondrial function related to different
metabolic pathways, and to analyze and interpret the data. This
approach appears suitable for the study of OXPHOS capacity in
healthy horses and evaluation of training programs in sport horses.
In addition, the technique could be used as a first line of functional
mitochondrial diagnosis in all suspected cases of equine neuro-
muscular disorders.
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